Facile Synthesis of H‐L‐Photo‐Lysine and Its Genetic Incorporation Into Proteins Authors: Abu Hamza, Chiranjeev Sharma, Yana Cen Published: 2026 ABSTRACT Photocrosslinking has emerged as a powerful tool for studying protein interactions in physiologically relevant conditions. Among various photoreactive groups, diazirine‐based noncanonical amino acids (ncAAs) are widely used due to their small size, stability, and high reactivity upon UV irradiation. Here, we report a convenient synthesis of H‐L‐photo‐lysine (photoK), a diazirine‐containing ncAA. The method offers improved yields, milder reaction conditions, and simplified purification. The synthetic photoK was successfully incorporated into a GFP variant via genetic code expansion, demonstrating its utility in protein labeling. Additionally, photoK was applied to study SIRT6, a human sirtuin with critical roles in genome stability, metabolism, and disease, yet with limited known substrates. Using a photoactivatable SIRT6K15photoK mutant, we confirmed its UV‐dependent crosslinking with histone H3, a known substrate. Application of SIRT6K15photoK in HEK293 cell lysates enabled the capture of potential physiological SIRT6 interaction partners. Photocrosslinking was also performed in Escherichia coli expressing SIRT6K15photoK. UV irradiation induced formation of protein conjugates, indicative of specific interactions with cellular binding partners. Importantly, pretreatment with a SIRT6‐selective inhibitor substantially reduced crosslinking, confirming interaction specificity. This approach provides a robust strategy for unbiased substrate profiling of SIRT6 and highlights the application of diazirine‐containing photocrosslinking in expanding the interactome of under‐studied enzymes. Introduction Photocrosslinking has emerged as a promising technology to study the interactions of proteins with small molecules, lipids, nucleic acids, or other proteins in physiologically relevant conditions [1, 2, 3]. A plethora of photocrosslinking groups such as benzophenone, aryl azide, diazirine, diazo, and acyl silanes have been developed to facilitate the covalent conjugation of proteins to their binding partners in a cellular environment [4, 5, 6]. Among these, diazirine has been extensively used as an efficient photoaffinity group because of its small size, high reactivity upon UV irradiation, and stability at physiological pH [7]. Numerous structurally and functionally diverse diazirine‐containing noncanonical amino acids (ncAAs) have been genetically incorporated into proteins using genetic code expansion [8, 9, 10]. The subsequence site‐directed photocrosslinking has been widely used to map protein interactomes. The importance of diazirine‐containing ncAAs in various biological investigations prompted us to develop a facile synthesis of these powerful chemical probes. In the current study, we focused on one particular ncAA called H‐L‐photo‐lysine (photoK). PhotoK (or DiAzK, Figure 1), a pyrrolysine analog carrying a diazirine photoreactive group, has proven to be effective in facilitating protein–protein crosslinking [11, 12]. PhotoK is commercially available from several vendors, although the price tends to be quite steep. Synthetic approaches to generate photoK also exist [12, 13, 14]. However, most of them suffer from low yield, harsh reaction conditions, and difficulty in purification. Herein, we report an efficient and concise strategy to synthesize photoK using commercially available Fmoc‐protected lysine for improved overall yield, mild reaction conditions, and purification easiness. The synthetic photoK is genetically incorporated into a GFP variant, sfGFP‐N149TAG, by amber codon suppression for a proof‐of‐concept testing. Comparison of photoK synthetic strategies. The human sirtuin family consists of seven members, SIRT1‐SIRT7 [15]. They demonstrate distinct enzymatic activities, subcellular localizations, and biological functions [16, 17, 18]. Through deacylating various cellular targets, human sirtuins regulate a wide range of biological events including genome stability [19], mitochondrial biogenesis [20], and metabolism [21], among many others. The clinical significance of sirtuins have also been increasingly recognized as they have been implicated in inflammation [22], metabolic disorders [23], and cancers [24]. Our knowledge on the physiological substrates of the seven human sirtuin isoforms differs widely. For the most extensively studied SIRT1, more than 100 endogenous substrates have been identified [19]. However, the number of confirmed substrates for other sirtuins such as SIRT6 is relatively small [25], hampering our understanding of their biological functions. SIRT6 was originally characterized as a histone deacetylase that targets specific sites of histone H3 [26, 27, 28]. Removal of these histone marks by SIRT6 is important for chromatin condensation, transcription repression, and DNA damage responses. Notably, SIRT6 is a complex enzyme with substrates beyond histone lysines. It deacetylates several nonhistone proteins involved in DNA repair and glucose homeostasis [29, 30]. The mounting evidence suggesting the critical functions of SIRT6 in cells is in strong contrast to the very few deacetylation targets that have been identified so far. Site‐specific antibody‐based methods such as Western blot have traditionally been conducted for SIRT6 substrate identification [29]. However, the development of antibodies is difficult, costly, and challenging to validate. Commonly employed synthetic peptides in combination with MS analysis led to the discovery of several histone substrates (H3K9Ac and H3K56Ac) [26, 27]. But it suffers from the low in vitro enzymatic turnover, which makes the data interpretation difficult. Thus, a robust substrate identification method for SIRT6 is imperatively needed. For unbiased profiling of SIRT6 substrates, we propose to utilize photoactivatable SIRT6 mutants to crosslink endogenous binding partners for further characterization. In the current study, photoK is successfully integrated into SIRT6 in a site‐specific manner, yielding the SIRT6K15photoK mutant. Upon UV exposure, SIRT6K15photoK is able to form covalent conjugate with histone H3, a known SIRT6 substrate. Furthermore, photocrosslinking of SIRT6K15photoK with HEK293 whole‐cell lysate captures multiple higher‐molecular‐weight species, consistent with the covalent trapping of potential physiological substrates. These results validate SIRT6K15photoK as a functional photocrosslinking probe and establish a platform for systematic identification of SIRT6 interaction partners. Results and Discussion Synthesis of PhotoK The existing photoK synthetic strategies start with a Boc‐protected lysine [12, 13, 14]. Acidic deprotection of Boc group is known to cause alkyl diazirine decomposition [13]. Furthermore, some of these approaches involve the use of highly toxic chemical [12], or ultralow temperature reaction, adding an additional layer of synthetic difficulty (Figure 1, “existing approaches”). We developed a facile synthesis of photoK using Fmoc‐Lys‐OH. 4‐Hydroxybutan‐2‐one (compound 1, Scheme 1) was treated with ammonia for 3 h at 0°C, followed by the addition of hydroxylamine‐O‐sulfonic acid. The reaction was allowed to warm to room temperature and stir overnight. After removal of the precipitation, the crude product was then treated with triethylamine and iodine to generate intermediate 2 with a 42% yield over two steps. Subsequently, intermediate 2 was incubated with N,N’‐disuccinimidyl carbonate and triethylamine, leading to the formation of an N‐hydroxysuccinimide (NHS) ester, intermediate 3, in 71% yield. The NHS ester reacted readily with the ε‐amino group in Fmoc‐Lys‐OH to afford intermediate 4 in quantitative yield. The Fmoc protecting group was then removed by 30% piperidine in CH3CN to form photoK in 60% yield. Synthesis of photoK. a. NH3, NH2OSO3H, MeOH, 0°C; b. Et3N, I2, MeOH, 0°C to RT (42% for two steps); c. N,N’‐disuccinimidyl carbonate, CH3CN, 0°C to RT (71%); d. Fmoc‐lysine, DMF (quantitatively); e. 30% piperidine, CH3CN (60%); f. 1N HCl, 4°C (quantitatively). PhotoK has low solubility in water (5 mg/mL) and DMSO (2 mg/mL). The solubility can be improved by converting it to the hydrochloride salt (50 mg/mL in water and 250 mg/mL in DMSO). Treatment of photoK with 1 N HCl at 4°C, followed by lyophilization, led to the formation of photoK hydrochloride in quantitative yield. 1H NMR spectra (DMSO‐d 6) of synthetic (made by our approach, Figure 2 top) and commercial photoK hydrochloride (Figure 2 bottom) appear to be identical. Comparison of 1H NMR spectra of synthetic and commercial photoK hydrochloride. Overall, the new synthetic approach reported here encompasses six steps with mild reaction conditions and good overall yield and avoids several previously reported harsh reagents or demanding reaction conditions. PhotoK hydrochloride is commercially available from Sigma–Aldrich and priced at $541 for 100 mg. Based on reagent, solvent, and consumable costs alone, the material expense to prepare 100 mg of photoK hydrochloride by our method is substantially lower than the current commercial price. This estimate does not include labor, instrumentation, or facility overhead costs. Overall, our strategy provides a convenient and economical lab‐scale route to access photoK. Genetic Incorporation of PhotoK Into sfGFP As a validation test, photoK was genetically incorporated into a GFP variant, superfolder green fluorescent protein (sfGFP) [31]. We resorted to the extensively employed orthogonal Methanosarcina barkeri pyrrolysyl‐tRNA synthetase and tRNAPyl CUA (MbPylRS/PylT) pair for the genetic code expansion [32, 33]. Two plasmids were used for sfGFP expression: One (pLei‐sfGFPN149TAG‐PylT) harbors the sfGFP with an amber codon placed at N149 and cognate tRNAPyl CUA, and the other (pBK‐MbPylRSY349F) has a M. barkeri tRNA synthetase mutant MbPylRSY349F. Both plasmids were cotransformed into Escherichia coli C321.ΔA cells [34]. PhotoK was readily genetically encodable using the MbPylRS mutant (Y349F) [35] paired up with PylT, as evidenced by the expression of sfGFPN149photoK only in the presence of photoK (Figure 3A). LC‐MS/MS analysis of purified sfGFP confirmed the site‐specific incorporation of photoK at residue 149 (Figure S2). Furthermore, the expression levels of sfGFP were comparable when either synthetic or commercial photoK was used (Figure 3B), suggesting that the incorporation efficiency of both photoK was similar. Genetic incorporation of photoK into sfGFP. (A) Bacterial expression and affinity purification of sfGFPN149photoK via amber codon suppression. (B) Comparison of sfGFP expression level using either commercial or synthetic photoK. Engineering and Characterization of Photocrosslinkable SIRT6 Mutant Human SIRT6, an NAD+‐dependent protein lysine deacylase, has emerged as a master regulator of a myriad of cellular events ranging from preventing genome instability to maintaining glucose homeostasis [21]. Despite its critical role in normal physiology and pathophysiology, only a handful of endogenous substrates of SIRT6 have been identified so far. Unbiased profiling of SIRT6 substrates is limited as traditional methods are not suitable for detecting the highly dynamic, context‐dependent, and often rather weak protein–protein interactions between SIRT6 and its cellular targets. Inspired by our initial success in incorporating photoK into sfGFP, we set out to integrate this ncAA into human SIRT6 for crosslink‐assisted substrate identification. Residue K15, located in close proximity to the catalytic site of SIRT6 and accessible from the substrate binding interface (Figure 4A), was chosen as the initial site for photoK incorporation because of its potential to capture transient substrate interactions while preserving the catalytic architecture. The corresponding codons were mutated into the amber codon, and the resulting gene was expressed together with MbPylRSY349F and PylT in bacteria in the presence of photoK (Figure 4B). MS analysis of purified SIRT6K15photoK confirmed the site‐specific incorporation of photoK (Figure 4C). HPLC assay [36] using synthetic H3K9Ac peptide as the substrate was used to assess the activity of SIRT6K15photoK. This mutant exhibited catalytic efficiency comparable to that of wildtype (wt) SIRT6 (Figure S3). In addition, residue K245 was evaluated as a second incorporation site and showed photoK‐dependent protein expression (Figure S4A). LC‐MS/MS analysis further confirmed the successful site‐specific incorporation of photoK at this position (Figure S4B), indicating that genetic code expansion in SIRT6 is not limited to a single permissive position. Engineering of SIRT6 mutant. (A) Crystal structure of SIRT6 (3PKI). (B) Bacterial expression and affinity purification of wtSIRT6 and SIRT6K15photoK. SIRT6K15photoK was not detected in the absence of photoK but was successfully expressed in the presence of photoK (0.5 mM). (C) LC‐MS/MS analysis of tryptic peptide that contains the position of incorporation (SIRT6K15photoK). In cellular studies, SIRT6 has a documented preference for acetylated histone H3 [26, 27]. SIRT6K15photoK was incubated with recombinant histone H3, followed by UV irradiation at 365 nm on ice. The samples were then analyzed by immunoblotting with an anti‐H3 antibody. As expected, a SIRT6‐H3 conjugate can be detected in a dose‐dependent manner (Figure 5A). Parallel immunoblot of the same crosslinking samples with an anti‐SIRT6 antibody revealed a corresponding UV‐dependent band at the same apparent molecular weight, further supporting the assignment of this species as the SIRT6‐H3 conjugate (Figure S5A). This crosslinking product was absent without UV irradiation, further confirming the conjugation was photoinitiated. Additional minor bands were observed and are likely attributable to partial degradation products and low‐abundance SIRT6 self‐crosslinked species generated during irradiation or sample processing. Crosslink‐assisted substrate identification. (A) Western blot to detect SIRT6‐H3 conjugate formation. (B) Photocrosslinking of recombinant SIRT6K15photoK with HEK293 cell lysate. Increasing amounts of SIRT6K15photoK were incubated with a fixed amount of cell lysate and irradiated at 365 nm. Samples were analyzed by anti‐SIRT6 immunoblotting. The higher molecular weight bands, indicated by red arrows, represent crosslinked proteins. Coomassie staining (Figure S5B) is shown as a loading control (Figure S5B). Representative results from three independent experiments are shown. (C) Photocrosslinking of SIRT6K15photoK‐expressing E. coli lysate in the presence or absence of OSS‐128167. Red arrows highlight crosslinked proteins with decreased band intensity in the presence of OSS‐128167. Coomassie staining is shown as a loading control. (D) Quantification of the Western blot results in (C). Quantification of crosslinked SIRT6 (% of total SIRT6) was performed by densitometric analysis of the high molecular weight species normalized to total SIRT6 signal in each lane. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by a Student’s t‐test: *p < 0.05 vs. control. The ability of SIRT6K15photoK to crosslink a full‐length histone protein suggests that the engineered protein is well‐suited for capturing SIRT6 substrates. Subsequently, SIRT6K15photoK was used to capture proteins interacting with SIRT6 in HEK293 whole‐cell lysate. The lysate was incubated with SIRT6K15photoK and NAD+ and then irradiated at 365 nm, with no UV as a control. The samples were resolved on an SDS‐PAGE and probed by Western blot using an anti‐SIRT6 antibody, revealing multiple high molecular weight bands in the UV‐treated samples (Figures 5B and S5B). Furthermore, the intensity of these bands increased in a concentration‐dependent fashion with increasing amounts of SIRT6K15photoK. These bands were only observed upon UV exposure. To directly assess proteins captured by this approach, photocrosslinked HEK293 lysate samples were subjected to immunoprecipitation (Figure S6) followed by LC‐MS/MS analysis. The resulting dataset identified the SIRT6 bait protein together with multiple candidate associated proteins, including histones and several chromatin‐ or genome‐associated factors such as PARP1, TP53BP1, TOP1, and BPTF (Table S1). These findings demonstrate that the photoK‐based crosslinking strategy can be integrated with downstream proteomic workflows to recover candidate SIRT6‐associated proteins from complex mammalian samples. To further evaluate the specificity and application of this crosslinking strategy, we next examined SIRT6K15photoK in a bacterial system. E. coli cells overexpressing SIRT6K15photoK in the presence of photoK were lysed, and the lysate was subjected to UV irradiation followed by Western blot analysis. Crosslinking experiments were also performed in the presence of a known SIRT6 inhibitor, OSS‐128167 [37], to assess whether inhibitor binding could block the capture of deacetylation substrates. As expected, upon UV irradiation, samples lacking inhibitor treatment exhibited multiple higher molecular weight bands (Figure 5C), consistent with the formation of covalent adducts between SIRT6 and its binding partners or substrates. In contrast, samples treated with OSS‐128167 showed a marked reduction or absence of high molecular weight species (Figure 5C,D). The inhibitor effectively blocked SIRT6’s interaction with its deacetylation substrates, thereby preventing their covalent capture. This result further supports the specificity of the crosslinking approach by demonstrating that formation of SIRT6‐containing crosslinked species can be reduced by pharmacological inhibition. In the bacterial lysate system, these species are interpreted as interacting proteins captured in a complex proteomic environment rather than physiological substrates. Conclusion In this study, we present a concise and efficient chemical synthesis of photoK, optimized for improved yield, mild conditions, and purification simplicity. The synthetic photoK was successfully incorporated into proteins in a site‐specific manner using genetic code expansion, as demonstrated by its incorporation into a GFP variant for validation. Building on this, we generated a photocrosslinkable SIRT6 mutant, SIRT6K15photoK, and demonstrated its ability to covalently conjugate to histone H3 under UV irradiation. Additionally, SIRT6K15photoK was utilized to probe potential endogenous binding partners in whole‐cell lysates. The resulting crosslinked products suggest the successful capture of candidate SIRT6‐interacting proteins in a complex proteomic environment. Subsequent immunoprecipitation and LC‐MS/MS analysis further identified SIRT6 bait protein together with histones and several chromatin‐associated factors, demonstrating compatibility of this platform with downstream proteomic workflows. To further assess the utility of this approach, photocrosslinking was conducted using E. coli cells overexpressing SIRT6K15photoK. Crosslinking occurred only upon UV exposure and resulted in multiple covalent conjugates, indicating interactions with cellular binding partners. Notably, the formation of these crosslinked species was significantly reduced in the presence of a SIRT6‐selective inhibitor, supporting the specificity of the photocrosslinking strategy. These findings underscore the potential of photoK as a powerful tool to elucidate protein–protein interactions in vitro and in vivo. Specifically, this strategy opens new avenues for discovering previously unrecognized substrates for less‐characterized sirtuin family members such as SIRT6. Given the growing recognition of SIRT6 in critical cellular processes and human disease, a comprehensive mapping of its interaction network will significantly advance our understanding of its biological roles. While diazirine‐based photocrosslinking is highly effective for capturing weak and transient interactions, the reactive carbene intermediate may also label nearby molecules in crowded environments. Accordingly, detected crosslinks may reflect spatial proximity rather than direct binding, and candidate interactions should therefore be validated using complementary biochemical and cellular approaches. An important next step will be to extend this strategy to intact mammalian cells by expressing photoactivatable SIRT6 variants through amber suppression, enabling in‐cell UV crosslinking followed by affinity enrichment and quantitative proteomic identification of physiological interaction partners. Integrating photocrosslinking with quantitative mass spectrometry and proteomic workflows will enable global profiling of SIRT6‐associated proteins. Such efforts may not only expand the known substrate repertoire of SIRT6 but also provide insights into its regulatory mechanisms and therapeutic potential across various disease contexts. Supporting Information Additional supporting information can be found online in the Supporting Information section. The authors have cited additional references within the Supporting Information [38]. Funding This study was supported by the National Institutes of Health (1R01GM143176‐01A1 and P30CA016059), National Science Foundation (CHE‐1846785), and George and Lavinia Blick Research Fund. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supplementary Material